Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

Clinical trial NCT00322335 · COMPLETED

Trial details

NCT number: NCT00322335
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Neisseria Meningitidis

Start date: 2006-05-01
Primary completion: 2006-07-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.